Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- 1. Organization and Basis of Presentation (Policies)
Notes Tables
Notes Details

11. Segment Reporting (Details-Operations)

v3.7.0.1

11. Segment Reporting (Details-Operations) - USD ($)	3 Months Ended
11. Segment Reporting (Details-Operations) - USD ($)	Mar. 31, 2017	Mar. 31, 2016
Net revenues - External	$ 1,176,113	$ 1,878,813
Net revenues - Inter Segment	78,326	296,348
(Loss) income from operations	(4,625,527)	(6,764,196)
Depreciation and amortization	592,945	727,270
Capital expenditures	1,090,922	19,002
Clinical Laboratory Operations [Member]
Net revenues - External	767,010	1,465,137
(Loss) income from operations	(1,341,998)	(2,650,540)
Depreciation and amortization	434,468	581,101
Capital expenditures	0	16,885
Supportive Software Solutions [Member]
Net revenues - External	236,945	230,026
Net revenues - Inter Segment	78,326	296,348
(Loss) income from operations	(718,546)	(1,313,313)
Depreciation and amortization	157,563	164,428
Capital expenditures	0	2,117
Decision Support and Informatics Operations [Member]
Net revenues - External	172,158	183,650
(Loss) income from operations	(301,001)	(881,566)
Depreciation and amortization	8,453	14,527
Hospital Operations [Member]
(Loss) income from operations	(467,316)	0
Capital expenditures	1,090,922	0
Corporate [Member]
(Loss) income from operations	(1,804,517)	(1,952,437)
Depreciation and amortization	312	875
Eliminations [Member]
(Loss) income from operations	7,851	33,660
Depreciation and amortization	$ (7,851)	$ (33,661)

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585

+ Details

Name:	us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 605
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68054470&loc=SL9156442-115640

+ Details

Name:	us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount, after sales adjustments, returns, allowances, and discounts, of revenue classified as other.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(a),(d))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_OtherSalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsForCapitalImprovements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=RNVA_ClinicalLaboratoryOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=RNVA_SupportiveSoftwareSolutionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=RNVA_DecisionSupportMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=RNVA_HospitalOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: